Vir Biotechnology stock kpis
Want to see VIR full AI Analyst Report?
Revenue by Segment
In Q2 2026, Vir Biotechnology reported revenue by segment of $238.94M (Collaboration) and $11.00K (Grant).
Provides insight into which business areas are driving sales, highlighting strengths and potential vulnerabilities in the company's revenue streams.
Revenue is clearly lumpy and milestone-driven—historical spikes came from a few large collaboration/contract recognitions while most recent quarters show a near-zero baseline as grant and contract receipts fade. The Astellas collaboration closed after quarter‑end and brings material near‑term cash and a pipeline of future milestones, but 40/60 development cost sharing and profit splits will blunt upside; going forward, timing of milestone recognition and clinical readouts, not recurring sales, will determine topline sustainability.
VIR Revenue by Segment
| Period | Collaboration | Grant | Contract |
|---|---|---|---|
| Q2 2026Jun 30, 2026 | $238.94M | $11.00K | $0.00 |
| Q1 2026Mar 31, 2026 | -$41.00K | $12.00K | $0.00 |
| Q4 2025Dec 31, 2025 | $63.76M | $310.00K | $0.00 |
| Q3 2025Sep 30, 2025 | -$65.00K | $305.00K | $0.00 |
| Q2 2025Jun 30, 2025 | -$495.00K | $183.00K | $1.53M |
| Q1 2025Mar 31, 2025 | -$70.00K | $1.24M | $1.86M |
| Q4 2024Dec 31, 2024 | $10.41M | $1.10M | $865.00K |
| Q3 2024Sep 30, 2024 | -$1.10M | $2.09M | $1.39M |
| Q2 2024Jun 30, 2024 | $55.00K | $2.13M | $886.00K |
| Q1 2024Mar 31, 2024 | -$1.00M | $5.20M | $52.20M |
| Q4 2023Dec 31, 2023 | $8.90M | $7.20M | $700.00K |
| Q3 2023Sep 30, 2023 | $4.39M | $6.74M | $289.00K |
| Q2 2023Jun 30, 2023 | -$13.78M | $16.52M | $1.06M |
| Q1 2023Mar 31, 2023 | $46.60M | $16.20M | $100.00K |
| Q4 2022Dec 31, 2022 | $21.60M | $27.60M | $200.00K |
| Q3 2022Sep 30, 2022 | $309.10M | $3.10M | $40.00M |
| Q2 2022Jun 30, 2022 | -$54.94M | $2.06M | $12.25M |
| Q1 2022Mar 31, 2022 | $1.23B | $2.52M | $282.00K |
| Q4 2021Dec 31, 2021 | $809.46M | $2.99M | $293.00K |
| Q3 2021Sep 30, 2021 | $102.40M | $903.00K | $315.00K |
| Q2 2021Jun 30, 2021 | $5.33M | $3.08M | $168.65M |
| Q1 2021Mar 31, 2021 | $0.00 | $1.37M | $605.00K |
| Q4 2020Dec 31, 2020 | $0.00 | $1.43M | $301.00K |
| Q3 2020Sep 30, 2020 | $0.00 | $1.74M | $188.00K |
| Q2 2020Jun 30, 2020 | $0.00 | $719.00K | $43.52M |
| Q1 2020Mar 31, 2020 | $0.00 | $5.23M | $487.00K |
| Q4 2019Dec 31, 2019 | $0.00 | $609.00K | $371.00K |
| Q3 2019Sep 30, 2019 | $0.00 | $1.17M | $237.00K |
| Q2 2019Jun 30, 2019 | $0.00 | $1.96M | $86.00K |
| Q1 2019Mar 31, 2019 | $0.00 | $3.64M | $17.00K |

